OncoZenge AB (publ) (FRA:8LY)
Germany · Delayed Price · Currency is EUR 0.4640
-0.0265 (-5.40%)
Last updated: Jan 28, 2026, 8:07 AM CET
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of €6.23 million as of January 30, 2026. Its market cap has increased by 22.54% in one year.
Market Cap
6.23M
Enterprise Value
5.84M
Revenue
251.72K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.46
Market Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has decreased from 8.84M to 6.23M, a decrease of -29.52%. That is a compound annual growth rate of -6.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 6.23M | -21.21% |
| Dec 30, 2025 | 7.91M | 106.31% |
| Dec 30, 2024 | 3.83M | 18.06% |
| Dec 29, 2023 | 3.25M | -43.86% |
| Dec 30, 2022 | 5.78M | -56.26% |
| Dec 30, 2021 | 13.22M | 49.56% |
| Feb 12, 2021 | 8.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MedNation AG | 8.65M |
| Altech Advanced Materials AG | 7.61M |
| Bio-Gate AG | 7.54M |
| BHB Brauholding Bayern-Mitte AG | 6.63M |
| BigRep SE | 5.97M |
| H2 Core AG | 5.32M |
| Lampetia AG | 5.10M |
| sdm SE | 5.02M |